+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Breast Cancer Liquid Biopsy Market by Product & Service, Circulating Biomarker and Application: Global Opportunity Analysis and Industry Forecast, 2019-2027

  • ID: 5321535
  • Report
  • February 2021
  • Region: Global
  • 305 Pages
  • Allied Analytics LLP
The global breast cancer liquid biopsy market was valued at $87,641 thousand in 2019, and is projected to reach $357,051 thousand by 2027, registering a CAGR of 19.2% from 2019 to 2027.



Breast cancer liquid biopsy is a non-invasive blood test that detects tumor DNA fragments and circulating tumor cells (CTCs), which are released into the blood from primary tumors and metastatic sites. Breast cancer liquid biopsy is a simple & precise alternative to surgical biopsy procedures, which allows physicians and surgeons to detect & treat breast cancer at an early stage and obtain tumor information through blood samples. Breast cancer liquid biopsy is particularly significant as it helps physicians to understand molecular changes and dynamics of breast cancer. Moreover, breast cancer recurrence is expected to be understood through well-timed breast cancer liquid biopsy techniques.

Rise in prevalence of breast cancer, increase in preference for noninvasive procedures, technological advancements in breast cancer liquid biopsy instruments, advantages of over solid tumor biopsy, and increase in patient awareness toward minimally invasive breast cancer liquid biopsy procedures are the key factors that fuel growth of the breast cancer liquid biopsy market. In addition, rise in funding for breast liquid biopsy R&D, favorable initiatives are undertaken by governments and global health organizations, and an increase in breast cancer liquid biopsy reagents approvals are another factor that contributes toward the growth of the market. However, limitations associated with liquid biopsy testing and lack of access and awareness regarding breast cancer liquid biopsy in underdeveloped countries are expected to hinder the growth of the market.

The global breast cancer liquid biopsy market is segmented on the basis of product & service, circulating biomarker, application, and region. By product & service, the market is categorized into reagent kits, instruments, and services. By circulating biomarker, it is segregated into circulating tumor cells, extracellular vesicles, and circulating tumor DNA. Depending on application, it is classified into diagnostics, prognostics, and risk assessment. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA

Key Benefits for Stakeholders


  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the

    KEY PLAYERS

    are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS


By Product & Service


  • Reagent Kits
  • Instruments
  • Services

By Circulating Biomarker


  • Circulating Tumor Cells
  • Extracellular Vesicles
  • Circulating Tumor DNA

By Application


  • Diagnostics
  • Prognostics
  • Risk Assessment

By Region


  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

List of Key Players profiled in the report


  • Biocept, Inc.
  • F. Hoffmann-La Roche Ltd. (Foundation Medicine, Inc.)
  • Fluxion Biosciences, Inc.
  • Menarini Group (Menarini Silicon Biosystems, Inc.)
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories, Inc.
  • Qiagen N.V.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

List of OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)


  • Isogen Life Science B.V.
  • Cynvenio Biosystems, Inc.
  • Biodesix, Inc.
Frequently Asked Questions about the Global Breast Cancer Liquid Biopsy Market

What is the estimated value of the Global Breast Cancer Liquid Biopsy Market?

The Global Breast Cancer Liquid Biopsy Market was estimated to be valued at $87641.0 thousand in 2019.

What is the growth rate of the Global Breast Cancer Liquid Biopsy Market?

The growth rate of the Global Breast Cancer Liquid Biopsy Market is 19.2%, with an estimated value of $357051.0 thousand by 2027.

What is the forecasted size of the Global Breast Cancer Liquid Biopsy Market?

The Global Breast Cancer Liquid Biopsy Market is estimated to be worth $357051.0 thousand by 2027.
Note: Product cover images may vary from those shown

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled in the Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Key Findings of the Study
2.2. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Force Analysis
3.4. Top Player Positioning, 2019
3.4.1. Breast Cancer
3.4.2. All Cancer Types
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Increase in Demand for Safe and Non-Invasive Procedures
3.5.1.2. Surge in Global Prevalence Rate of Breast Cancer
3.5.1.3. Advantages of Breast Cancer Liquid Biopsy Tests Over Traditional Tests
3.5.2. Restraint
3.5.2.1. Lack of Access and Awareness in Underdeveloped Countries
3.5.3. Opportunity
3.5.3.1. High Growth Potential in Emerging Markets
3.5.4. Impact Analysis
3.6. Pricing Analysis
3.7. Reimbursement Scenario
3.8. Clinical Validations
3.9. Regulatory Landscape
3.10. List of Approved Liquid Biopsy Tests
Chapter 4: Breast Cancer Liquid Biopsy Market, by Product & Service
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Reagent Kits
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Instruments
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.4. Services
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
Chapter 5: Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Circulating Tumor Cells
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Extracellular Vesicles
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Circulating Tumor Dna
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
Chapter 6: Breast Cancer Liquid Biopsy Market, by Application
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Diagnostics
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Prognostics
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
6.4. Risk Assessment
6.4.1. Market Size and Forecast, by Region
6.4.2. Market Analysis, by Country
Chapter 7: Breast Cancer Liquid Biopsy Market, by Region
7.1. Overview
7.1.1. Market Size and Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.2.2. Market Size and Forecast, by Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Breast Cancer Liquid Biopsy Market, by Product & Service
7.2.2.1.2. U.S. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.2.2.1.3. U.S. Breast Cancer Liquid Biopsy Market, by Application
7.2.2.2. Canada
7.2.2.2.1. Canada Breast Cancer Liquid Biopsy Market, by Product & Service
7.2.2.2.2. Canada Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.2.2.2.3. Canada Breast Cancer Liquid Biopsy Market, by Application
7.2.2.3. Mexico
7.2.2.3.1. Mexico Breast Cancer Liquid Biopsy Market, by Product & Service
7.2.2.3.2. Mexico Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.2.2.3.3. Mexico Breast Cancer Liquid Biopsy Market, by Application
7.2.3. North America Market Size and Forecast, by Product & Service
7.2.4. North America Market Size and Forecast, by Circulating Biomarker
7.2.5. North America Market Size and Forecast, by Application
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, and Opportunities
7.3.2. Market Size and Forecast, by Country
7.3.2.1. Germany
7.3.2.1.1. Germany Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.1.2. Germany Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.1.3. Germany Breast Cancer Liquid Biopsy Market, by Application
7.3.2.2. France
7.3.2.2.1. France Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.2.2. France Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.2.3. France Breast Cancer Liquid Biopsy Market, by Application
7.3.2.3. UK
7.3.2.3.1. UK Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.3.2. UK Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.3.3. UK Breast Cancer Liquid Biopsy Market, by Application
7.3.2.4. Italy
7.3.2.4.1. Italy Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.4.2. Italy Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.4.3. Italy Breast Cancer Liquid Biopsy Market, by Application
7.3.2.5. Spain
7.3.2.5.1. Spain Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.5.2. Spain Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.5.3. Spain Breast Cancer Liquid Biopsy Market, by Application
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Breast Cancer Liquid Biopsy Market, by Product & Service
7.3.2.6.2. Rest of Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.3.2.6.3. Rest of Europe Breast Cancer Liquid Biopsy Market, by Application
7.3.3. Europe Market Size and Forecast, by Product & Service
7.3.4. Europe Market Size and Forecast, by Circulating Biomarker
7.3.5. Europe Market Size and Forecast, by Application
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, and Opportunities
7.4.2. Market Size and Forecast, by Country
7.4.2.1. Japan
7.4.2.1.1. Japan Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.1.2. Japan Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.1.3. Japan Breast Cancer Liquid Biopsy Market, by Application
7.4.2.2. China
7.4.2.2.1. China Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.2.2. China Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.2.3. China Breast Cancer Liquid Biopsy Market, by Application
7.4.2.3. India
7.4.2.3.1. India Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.3.2. India Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.3.3. India Breast Cancer Liquid Biopsy Market, by Application
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service
7.4.2.4.2. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.4.2.4.3. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application
7.4.3. Asia-Pacific Market Size and Forecast, by Product & Service
7.4.4. Asia-Pacific Market Size and Forecast, by Circulating Biomarker
7.4.5. Asia-Pacific Market Size and Forecast, by Application
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, and Opportunities
7.5.2. Market Size and Forecast, by Country
7.5.2.1. Latin America
7.5.2.1.1. Latin America Breast Cancer Liquid Biopsy Market, by Product & Service
7.5.2.1.2. Latin America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.5.2.1.3. Latin America Breast Cancer Liquid Biopsy Market, by Application
7.5.2.2. Middle East
7.5.2.2.1. Middle East Breast Cancer Liquid Biopsy Market, by Product & Service
7.5.2.2.2. Middle East Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.5.2.2.3. Middle East Breast Cancer Liquid Biopsy Market, by Application
7.5.2.3. Africa
7.5.2.3.1. Africa Breast Cancer Liquid Biopsy Market, by Product & Service
7.5.2.3.2. Africa Breast Cancer Liquid Biopsy Market, by Circulating Biomarker
7.5.2.3.3. Africa Breast Cancer Liquid Biopsy Market, by Application
7.5.3. LAMEA Market Size and Forecast, by Product & Service
7.5.4. LAMEA Market Size and Forecast, by Circulating Biomarker
7.5.5. LAMEA Market Size and Forecast, by Application
Chapter 8: Company Profiles
8.1. Biocept Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves and Developments
8.2. F. Hoffmann-La Roche Ltd. (Foundation Medicine, Inc.)
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.2.6. Key Strategic Moves and Developments
8.3. Fluxion Biosciences, Inc.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.4. Menarini Group (Menarini Silicon Biosystems, Inc.)
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Key Strategic Moves and Developments
8.5. Myriad Genetics, Inc.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.6. Neogenomics Laboratories, Inc.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves and Developments
8.7. Qiagen N. V.
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.7.6. Key Strategic Moves and Developments
8.8. Sysmex Corporation
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.9. Thermo Fisher Scientific, Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Guardant Health, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves and Developments
List of Tables
Table 01. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 02. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 03. Reagent Kits Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 04. Reagent Kits Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 05. Instruments Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 06. Instruments Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 07. Service Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 08. Service Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 09. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 10. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 11. Circulating Tumor Cells Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 12. Circulating Tumor Cells Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 13. Extracellular Vesicles Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 14. Extracellular Vesicles Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 15. Circulating Tumor Dna Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 16. Circulating Tumor Dna Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 17. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 18. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 19. Diagnostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 20. Diagnostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 21. Prognostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 22. Prognostics Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 23. Risk Assessment Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 24. Risk Assessment Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 25. Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 ($Thousand)
Table 26. Breast Cancer Liquid Biopsy Market, by Region, 2019-2027 (Units)
Table 27. North America Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 28. North America Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 29. U.S. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 30. U.S. Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 31. U.S. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 32. U.S. Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 33. U.S. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 34. U.S. Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 35. Canada Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 36. Canada Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 37. Canada Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 38. Canada Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 39. Canada Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 40. Canada Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 41. Mexico Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 42. Mexico Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 43. Mexico Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 44. Mexico Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 45. Mexico Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 46. Mexico Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 47. North America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 48. North America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 49. North America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 50. North America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 51. North America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 52. North America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 53. Europe Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 54. Europe Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 55. Germany Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 56. Germany Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 57. Germany Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 58. Germany Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 59. Germany Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 60. Germany Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 61. France Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 62. France Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 63. France Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 64. France Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 65. France Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 66. France Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 67. UK Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 68. UK Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 69. UK Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 70. UK Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 71. UK Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 72. UK Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 73. Italy Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 74. Italy Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 75. Italy Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 76. Italy Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 77. Italy Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 78. Italy Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 79. Spain Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 80. Spain Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 81. Spain Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 82. Spain Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 83. Spain Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 84. Spain Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 85. Rest of Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 86. Rest of Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 87. Rest of Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 88. Rest of Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 89. Rest of Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 90. Rest of Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 91. Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 92. Europe Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 93. Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 94. Europe Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 95. Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 96. Europe Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 97. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 98. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 99. Japan Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 100. Japan Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 101. Japan Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 102. Japan Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 103. Japan Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 104. Japan Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 105. China Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 106. China Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 107. China Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 108. China Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 109. China Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 110. China Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 111. India Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 112. India Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 113. India Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 114. India Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 115. India Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 116. India Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 117. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 118. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 119. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 120. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 121. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 122. Rest of Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 123. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 124. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 125. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 126. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 127. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 128. Asia-Pacific Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 129. LAMEA Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 ($Thousand)
Table 130. LAMEA Breast Cancer Liquid Biopsy Market, by Country, 2019-2027 (Units)
Table 131. Latin America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 132. Latin America Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 133. Latin America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 134. Latin America Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 135. Latin America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 136. Latin America Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 137. Middle East Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 138. Middle East Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 139. Middle East Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 140. Middle East Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 141. Middle East Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 142. Middle East Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 143. Africa Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 144. Africa Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 145. Africa Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 146. Africa Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 147. Africa Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 148. Africa Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 149. LAMEA Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 ($Thousand)
Table 150. LAMEA Breast Cancer Liquid Biopsy Market, by Product & Service, 2019-2027 (Units)
Table 151. LAMEA Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 ($Thousand)
Table 152. LAMEA Breast Cancer Liquid Biopsy Market, by Circulating Biomarker, 2019-2027 (Units)
Table 153. LAMEA Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 ($Thousand)
Table 154. LAMEA Breast Cancer Liquid Biopsy Market, by Application, 2019-2027 (Units)
Table 155. Biocept: Company Snapshot
Table 156. Biocept: Product Portfolio
Table 157. Biocept: Key Strategic Moves and Developments
Table 158. Roche: Company Snapshot
Table 159. Roche: Operating Segment
Table 160. Roche: Product Portfolio
Table 161. Roche: Key Strategic Moves and Developments
Table 162. Fluxion: Company Snapshot
Table 163. Fluxion: Product Portfolio
Table 164. Menarini: Company Snapshot
Table 165. Menarini: Product Portfolio
Table 166. Menarini: Key Strategic Moves and Developments
Table 167. Myriad: Company Snapshot
Table 168. Myriad: Operating Segments
Table 169. Myriad: Product Portfolio
Table 170. Neogenomics: Company Snapshot
Table 171. Neogenomics: Operating Segment
Table 172. Neogenomics: Product Portfolio
Table 173. Neogenomics: Key Strategic Moves and Developments
Table 174. Qiagen: Company Snapshot
Table 175. Qiagen: Operating Segment
Table 176. Qiagen: Product Portfolio
Table 177. Qiagen: Key Strategic Moves and Developments
Table 178. Sysmex: Company Snapshot
Table 179. Sysmex: Oerating Segment
Table 180. Sysmex.: Product Portfolio
Table 181. Thermo Fisher: Company Snapshot
Table 182. Thermo Fisher.: Operating Segment
Table 183. Thermo Fisher.: Product Portfolio
Table 184. Guardant: Company Snapshot
Table 185. Guardant: Operating Segment
Table 186. Guardant: Product Portfolio
Table 187. Guardant: Key Strategic Moves and Developments
List of Figures
Figure 01. Top Investment Pockets
Figure 02. Top Winning Strategies, by Year, 2017-2020*
Figure 03. Top Winning Strategies, by Development, 2017-2020* (%)
Figure 04. Top Winning Strategies, by Company, 2017-2020* (%)
Figure 05. Top Player Positioning, 2019
Figure 01. Value Chain Analysis of Pharmaceutical Packaging Market
Figure 02. Moderate Bargaining Power of Buyers
Figure 03. Moderate Bargaining Power of Suppliers
Figure 04. Moderate Threat of New Entrants
Figure 05. Moderate Threat of Substitution
Figure 06. High Competitive Rivalry
Figure 07. Impact Analysis:
Figure 08. Comparative Share Analysis of Plastic Bottle Market, by Country, 2019 & 2027(%)
Figure 09. Comparative Share Analysis of Parenteral Containers Market, by Country, 2019 & 2027(%)
Figure 10. Comparative Share Analysis of Blister Packaging Market, by Country, 2019 & 2027(%)
Figure 11. Comparative Share Analysis of Specialty Bags Market, by Country, 2019 & 2027(%)
Figure 12. Comparative Share Analysis of Closures Market, by Country, 2019 & 2027(%)
Figure 13. Comparative Share Analysis of Labels Market, by Country, 2019 & 2027(%)
Figure 14. Comparative Share Analysis of Others Market, by Country, 2019 & 2027(%)
Figure 15. Comparative Share Analysis of Glass Market, by Country, 2019 & 2027(%)
Figure 16. Comparative Share Analysis of Aluminium Foil Market, by Country, 2019 & 2027(%)
Figure 17. Comparative Share Analysis of Plastics and Polymers Market, by Country, 2019 & 2027(%)
Figure 18. Comparative Share Analysis of Paper and Paperboard Market, by Country, 2019 & 2027(%)
Figure 19. Comparative Share Analysis of Others Market, by Country, 2019 & 2027(%)
Figure 20. U.S. Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 21. Canada Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 22. Mexico Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 23. Germany Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 24. France Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 25. UK Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 26. Italy Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 27. Spain Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 28. Rest of Europe Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 29. Japan Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 30. China Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 31. Australia Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 32. India Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 33. South Korea Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 34. Rest of Asia-Pcaific Pharmaceutical Packaging Market, 2019-2027 ($Million)
Figure 35. Brazil Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 36. Saudi Arabia Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 37. South Africa Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 38. Rest of LAMEA Pharmaceutical Packagingmarket, 2019-2027 ($Million)
Figure 39. Amcor: Net Sales, 2018-2020 ($Million)
Figure 40. Amcor: Revenue Share by Segment, 2020 (%)
Figure 41. Amcor: Revenue Share by Region, 2020 (%)
Figure 42. Aptar: Net Sales, 2017-2019 ($Million)
Figure 43. Aptar: Revenue Share by Segment, 2019 (%)
Figure 44. Aptar: Revenue Share by Region, 2019 (%)
Figure 45. Bd: Net Sales, 2017-2019 ($Million)
Figure 46. Bd: Revenue Share by Segment, 2019 (%)
Figure 47. Bd: Revenue Share by Region, 2019 (%)
Figure 48. Berry: Net Sales, 2017-2019 ($Million)
Figure 49. Berry: Revenue Share by Segment, 2019 (%)
Figure 50. Berry: Revenue Share by Region, 2019 (%)
Figure 51. Catalent: Net Sales, 2018-2020 ($Million)
Figure 52. Catalent: Revenue Share by Segment, 2020 (%)
Figure 53. Catalent: Revenue Share by Region, 2020 (%)
Figure 54. Ccl: Net Sales, 2017-2019 ($Million)
Figure 55. Ccl: Revenue Share by Segment, 2019 (%)
Figure 56. Ccl: Revenue Share by Region, 2019 (%)
Figure 57. Gerresheimer: Net Sales, 2017-2019 ($Million)
Figure 58. Gerresheimer: Revenue Share by Segment, 2019 (%)
Figure 59. Gerresheimer: Revenue Share by Region, 2019 (%)
Figure 60. Nipro Group: Net Sales, 2018-2020 ($Million)
Figure 61. Nipro Group: Revenue Share by Segment, 2020 (%)
Figure 62. Nipro Group: Revenue Share by Region, 2020 (%)
Figure 63. Schott Ag: Net Sales, 2017-2019 ($Million)
Figure 64. Schott Ag: Revenue Share by Segment, 2019 (%)
Figure 65. Schott Ag: Revenue Share by Region, 2019 (%)
Figure 66. West: Net Sales, 2017-2019 ($Million)
Figure 67. West: Revenue Share by Segment, 2019 (%)
Figure 68. West: Revenue Share by Region, 2019 (%)
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...